William Blair & Company
STIM icon

William Blair & Company’s Neuronetics STIM Stock Holding History

William Blair & Company’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,252
Closed -$7.79K – 1882
2024
Q3 		$7.79K Sell
10,252
-337
-3% -$442 ﹤0.01% 1764
2024
Q2 		$19.1K Buy
+10,589
New +$30.5K ﹤0.01% 1692
2024
Q1 		– Sell
-11,379
Closed -$33K – 1846
2023
Q4 		$33K Sell
11,379
-79,827
-88% -$126K ﹤0.01% 1623
2023
Q3 		$123K Sell
91,206
-11,088
-11% -$19.4K ﹤0.01% 1473
2023
Q2 		$220K Sell
102,294
-55,427
-35% -$134K ﹤0.01% 1373
2023
Q1 		$459K Sell
157,721
-15,775
-9% -$79.5K ﹤0.01% 1077
2022
Q4 		$1.19M Sell
173,496
-551
-0.3% -$2.6K 0.01% 775
2022
Q3 		$553K Buy
174,047
+7,407
+4% +$26.9K ﹤0.01% 1003
2022
Q2 		$535K Sell
166,640
-27,083
-14% -$78.6K ﹤0.01% 1042
2022
Q1 		$587K Buy
193,723
+21,137
+12% +$71.4K ﹤0.01% 1102
2021
Q4 		$770K Buy
172,586
+14,067
+9% +$68.9K ﹤0.01% 1049
2021
Q3 		$1.04M Buy
158,519
+3,162
+2% +$30.3K ﹤0.01% 907
2021
Q2 		$2.49M Buy
155,357
+5,242
+3% +$72.4K 0.01% 638
2021
Q1 		$1.86M Buy
150,115
+4,780
+3% +$73.3K 0.01% 711
2020
Q4 		$1.61M Buy
145,335
+1,667
+1% +$12.5K 0.01% 709
2020
Q3 		$698K Buy
143,668
+8,065
+6% +$30.6K ﹤0.01% 873
2020
Q2 		$262K Sell
135,603
-22,430
-14% -$46K ﹤0.01% 1147
2020
Q1 		$299K Buy
158,033
+65,100
+70% +$204K ﹤0.01% 1016
2019
Q4 		$417K Sell
92,933
-52,565
-36% -$327K ﹤0.01% 1055
2019
Q3 		$1.21M Buy
145,498
+44,215
+44% +$483K 0.01% 697
2019
Q2 		$1.27M Sell
101,283
-23,585
-19% -$333K 0.01% 699
2019
Q1 		$1.9M Sell
124,868
-1,652
-1% -$27.3K 0.01% 577
2018
Q4 		$2.45M Buy
+126,520
New +$2.78M 0.02% 482

Other funds holding STIM

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

William Blair & Company's STIM Position: Q4 2024 in Review

William Blair & Company sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 10,252 shares — an estimated $7.79K sold.

William Blair & Company first reported a position in STIM in Q4 2018 and held it in 23 quarters. The position peaked at $2.49M in Q2 2021. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

  • William Blair & Company reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
  • William Blair & Company sold 10,252 Neuronetics shares in Q4 2024, an estimated $7.79K.
  • William Blair & Company first reported a position in Neuronetics in Q4 2018 and held it in 23 quarters.
  • William Blair & Company's Neuronetics position peaked at $2.49M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on William Blair & Company's 13F filing for Q4 2024, filed 12 Feb 2025.